# Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis

> **NCT02047539** · EARLY_PHASE1 · TERMINATED · sponsor: **Yale University** · enrollment: 1 (actual)

## Conditions studied

- Clinical High Risk for Psychosis

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02047539
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-01
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2021-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02047539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02047539, "Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02047539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*